Home   /   Pressrelease    /   

XPS to Switzerland

XPS™ to Switzerland

The University Hospital in Lausanne CHUV, Switzerland has decided to acquire the Xvivo Perfusion system, XPS™. This is the first XPS™ to a Swiss hospital. It is estimated that delivery and installation of the XPS™ will take place in March 2016.

The XPS™ is the only system on the market for Ex Vivo Lung Perfusion (EVLP) that is approved on all major markets, including US approval by the FDA. The XPS™ system gives the user the flexibility to perform evaluation of lungs for transplantation using a standardized and simplified procedure. The XPS™ has achieved good clinical results when used at leading clinics in the USA and Europe. In Europe, five clinics will have the XPS™-system, whereof one clinic in Switzerland..

“We are very pleased that the clinic in Lausanne, which is one of the most important clinics in Switzerland, now starts to use XPS™ to facilitate EVLP," says Magnus Nilsson, CEO of XVIVO Perfusion.

January 29, 2016
Gothenburg
XVIVO Perfusion AB (publ)

Fill out the form to watch the video